ESSA Pharma's market cap is currently ―. The company's EPS TTM is $-0.585; its P/E ratio is -10.39; ESSA Pharma is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -5.96M	$ -5.48M	$ -7.30M	$ -7.06M	$ -7.85M
EBITDA	$ -5.96M	$ -5.64M	-	-	$ -7.91M
Net Income Common Stockholders	$ -5.96M	$ -5.48M	$ -7.30M	$ -7.06M	$ -6.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 142.12M	$ 148.08M	$ 152.47M	$ 157.04M	$ 163.07M
Total Assets	$ 144.49M	$ 149.12M	$ 153.65M	$ 158.50M	$ 165.00M
Total Debt	$ 374.83K	$ 80.33K	$ 111.27K	$ 145.27K	$ 177.96K
Net Debt	$ -141.74M	$ -148.00M	$ -152.36M	$ -156.90M	$ -162.89M
Total Liabilities	$ 3.81M	$ 3.50M	$ 3.41M	$ 2.17M	$ 2.98M
Stockholders Equity	$ 140.68M	$ 145.63M	$ 150.24M	$ 156.34M	$ 162.02M
Cash Flow	-
Free Cash Flow	$ -6.79M	$ -4.49M	-	-	$ -4.99M
Operating Cash Flow	$ -6.79M	$ -4.49M	-	-	$ -4.99M
Investing Cash Flow	$ 8.23M	$ -264.65K	-	-	$ -876.34K
Financing Cash Flow	$ 196.66K	$ -13.65K	-	-	$ 15.65K

Currency in USD

ESSA Pharma Earnings and Revenue History

Income Statement >

ESSA Pharma Debt to Assets

Balance Sheet >

ESSA Pharma Cash Flow

Cash Flow >

ESSA Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing